Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.